Treatment Considerations in Patients who have Bipolar Disorder and are Pregnant or Postpartum
This session will focus on reviewing bipolar disorder in pregnant and postpartum patients. We will examine the benefits and risks associated with specific mood stabilizers, as well as the potential risks of withholding therapy on the dyad. Additionally, we will delve into the CANMAT bipolar disorder guidelines and the ACOG guidelines for psychiatric care in pregnant and postpartum individuals.
- Analyze the efficacy, risks, and benefits of using or withholding psychiatric medications for bipolar disorder during the prenatal and peripartum periods.
- Evaluate current guideline recommendations and recent literature describing the use of psychiatric medications in pregnant patients with bipolar disorder.
Stephanie NicholsPharmD, BCPP, MPH
Stephanie Nichols, PharmD, BCPS, BCPP is an Associate Professor in the University of New England College of Pharmacy, Adjunct Clinical Assistant Professor of Psychiatry in the Tufts University School of Medicine, and a Psychiatric and Substance Use Disorder (SUD) Pharmacist at Maine Medical Center in Portland. She graduated from the University at Buffalo with her Doctor of Pharmacy degree and completed an Inpatient Pharmacy Practice Residency at Maine Medical Center. Dr. Nichols is dual board certified as a Pharmacotherapy Specialist (BCPS) and a Psychiatric Pharmacist (BCPP) and is a fellow of the American College of Clinical Pharmacy (FCCP).